Aurobindo Pharma gets US FDA nod for generic osteoporosis drug

Aurobindo Pharma has received approval from the US FDA to manufacture and market its generic version of Eli Lilly's Evista tablets used to treat and prevent osteoporosis.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news